浏览其他金融产品
Avidity Biosciences, Inc.
RNAM重点摘要
最后更新: 2026-04-13- •Replimune (REPLI) closed at $4.76 on April 10, 2026 — a ~20% single-day drop and 51% YTD decline following a second FDA Complete Response Letter for RP1.
- •Leverage risk is extreme: a 50x long CFD opened at $5.91 would have been liquidated intraday, as the 20% decline represents ~10x the initial margin at that leverage level.
- •A February 2026 SEC filing warned a second rejection could make RP1 development 'no longer viable,' with Phase 3 completion not expected until January 2029.
- •Cross-market contagion targets biotech ETFs (XBI, IBB) as the FDA rejection reinforces sector-wide regulatory uncertainty flagged by nearly half of RBC Capital Markets-surveyed investors.
- •FDA leadership transition (Vinay Prasad departing by end of April 2026) adds short-term regulatory uncertainty across clinical-stage oncology names.
价格与市场结构
交易制度状态
术语表
关键上市股票与 CFD 词汇,每个一句 —— 让页面对读者和 AI 引擎都清晰无歧义。
| 股票差价合约 | 针对股价的差价合约 —— 仅取得价格敞口,并不拥有相关股份。 |
|---|---|
| 延长时段 | 在交易所常规时段以外的盘前及盘后交易。 |
| 基差风险 | 差价合约参考价与交易所成交价未必同步变动的风险。 |
| 市盈率 | 市盈率 = 股价 ÷ 每股盈利;常用的估值指标。 |
| 毛利率 | 毛利 ÷ 营收;反映产品层面的盈利能力。 |
| 每股盈利 | 每股盈利 = 净利润 ÷ 摊薄后流通股数。 |
最新动态
Replimune因第二次FDA拒绝而大幅下跌56%:杠杆风险与生物技术行业传染
根据FierceBiotech和BioPharma Dive的报道,美国食品药品管理局(FDA)于2026年4月10日发出第二份完整回应信(CRL),拒绝了Replimune Group(纳斯达克:REPLI)的RP1(vusolimogene oderparepvec)用于不可切除的晚期皮肤黑色素瘤的申请。FDA的治疗产品办公室一致认为,来自1/2期Ignyte试验的数据"不足以得出有效性的实质
Replimune的第二次FDA拒绝:裁员信号对生物科技CFD交易者的二元风险崩溃
在2026年4月10日,美国食品药品监督管理局(FDA)发出第二封完整应答信(CRL),拒绝了Replimune Group, Inc.(纳斯达克:REPL)重新提交的生物制剂申请(BLA),该申请针对RP1(vusolimogene oderparepvec),这是一种结合Bristol Myers Squibb的Opdivo的针对晚期黑色素瘤的肿瘤溶解免疫疗法。据FierceBiotech和S
Replimune的RP1面临第二次FDA判决:2026年4月10日对生物科技CFD交易者意味着什么
Replimune Group Inc.(NASDAQ: REPL)于2025年7月22日收到了FDA的完整回应信(CRL),拒绝了其针对RP1——一种溶瘤单纯疱疹病毒——与百时美施贵宝的nivolumab(Opdivo)联合用于抗PD-1耐药的晚期黑色素瘤的生物制剂许可申请(BLA)。根据FierceBiotech和STAT News报道,FDA认为单臂IGNYTE试验(n=140)不足,指出缺
Get Started with Avidity Biosciences, Inc.
Start trading Avidity Biosciences, Inc. on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade RNAM CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Avidity Biosciences, Inc.: Step-by-Step Guide
Learn how to trade Avidity Biosciences, Inc. (RNAM) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find RNAM in the Stocks Section
Navigate to the stocks market section and search for RNAM. You can trade Avidity Biosciences, Inc. as a CFD with up to 1000x leverage.
- ✓Search for "RNAM" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Avidity Biosciences, Inc..
- ✓Long (buy) if you expect RNAM to rise
- ✓Short (sell) if you expect RNAM to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
标签
Similar Stocks Assets
Explore other stocks instruments in the same sector as Avidity Biosciences, Inc.. Compare performance and find trading opportunities.
ProShares UltraShort Silver

AeroVironment, Inc.

Tempus AI, Inc

Ondas Holdings Inc.

TransUnion
免责声明与参考资料
重要风险提示
CoinUnited 股票差价合约只提供 Avidity Biosciences, Inc. 的价格敞口,并非股权拥有:没有股东投票权、没有股息,亦不会以相关股票交收。
杠杆同时放大亏损与盈利,仓位可能在相关股价回升之前已被强制平仓。相关股票按交易所时段挂牌,参考价可能在时段之间跳空。
用户在做出任何投资决策前,应自行进行充分研究,并咨询具有专业资质的金融顾问。平台开发方与运营方不对因依赖所提供信息而造成的任何财务损失或其他后果承担责任。
杠杆交易风险极高,可能损失全部本金。
方法论概览
本页数据来自一手及具名第三方来源,并非由预测模型产生。每一项的来源与日期均列于上方的出处对照表。
- 财务报表:公司自身的 SEC 申报文件(10-K/10-Q),由 XBRL 读取
- 市场数据:CoinUnited 参考价及每日收市价
- 机构持股:SEC Form 13F 季度申报
- 分析师目标价:聚合的第三方卖方研究 — 属第三方意见,并非 CoinUnited 观点
- 同业倍数:第三方过去十二个月比率
CoinUnited 不会就 Avidity Biosciences, Inc. 发布价格预测或目标价。
上次方法论审阅时间:
准备好开始交易 Avidity Biosciences, Inc. 了吗?
加入数千名交易者,今天就开始您的 Avidity Biosciences, Inc. 交易之旅。获得先进的交易工具和具竞争力的费用。



